Your body needs time to adapt to the changes brought about by Ozempic
Both medications work by slowing digestion, increasing satiety, and regulating insulin response helping you eat less and lose more
IGF-1 LR3 is not approved for therapeutic use in humans and is intended strictly for research purposes
A new reality: GLP-1 as a personal experiment Many women describe their experience as: observing changes comparing cycles trying to interpret patterns Im basically figuring it out as I go. Mira survey participant GLP-1 medications are no longer just a metabolic conversation
For instance, a large-scale retrospective cohort study utilizing the Taiwanese National Health Insurance Research Database demonstrated that patients with tinnitus had a significantly higher risk of subsequently developing AD (adjusted hazard ratio 1.54) and PD (adjusted hazard ratio 1.56) over a 10-year follow-up period, positioning tinnitus as a potential soft sign or risk factor for these neurodegenerative conditions (Chu et al., 2020)
Are at high risk (e.g., older adults, people with darker skin, those with limited sun exposure)
